India's Alkem Laboratories unit to buy up to 55% stake in Occlutech Holding for 99.4 million euros
13/02/2026 09:19
BENGALURU, Feb 13 (Reuters) - Alkem Laboratories' ALKE.NS medical devices unit will buy a stake of up to 55% in Switzerland-based Occlutech Holding for 99.4 million euros ($117.9 million), the pharmaceutical company said on Friday. ($1 = 0.8430 euros) (Reporting by Nishit Navin; Editing by Sonia Cheema) ((Nishit.Navin@thomsonreuters.com;))
Recent news on Alkem Laboratories
See all newsBrief: Alkem Labs Approved Initiation Of Forensic Audit In Connection With Recent Incident Involving Alleged Misappropriation Of Funds By A Former Employee
Brief: Alkem Labs Launches Neuceno (Cenobamate) For Treatment Of Partial-Onset Seizures In Adult Patients
Brief: Alkem Labs Launches Renocia Exo, Ginsenoside Exosome-Based Hair Growth Serum
Brief: Alkem Labs Board Approves Investment Of Up To 750 Million Rupees For New Block At Baddi Manufacturing Facility
Brief: Alkem Laboratories Q1 Consol Revenue From Operations 37.4 Billion Rupees